RMD gears up for fiscal Q3 earnings with steady estimates, rising demand in sleep devices and AI-driven digital health tools poised to shape results.
ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Lbp Am Sa Buys 18,142 Shares of ResMed Inc. $RMD

04:34am, Saturday, 18'th Apr 2026
Lbp Am Sa boosted its stake in shares of ResMed Inc. (NYSE: RMD) by 364.1% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The
RMD's growth strategy, rising device demand and solid finances support momentum, but macro pressures and stiff competition could test its outlook.
ResMed Inc. (NYSE: RMD - Get Free Report) CEO Michael Farrell sold 4,991 shares of the stock in a transaction that occurred on Tuesday, April 7th. The stock was sold at an average price of $225.50, fo
Aaron Wealth Advisors LLC lessened its stake in shares of ResMed Inc. (NYSE: RMD) by 53.3% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission
Azzad Asset Management Inc. ADV lifted its position in shares of ResMed Inc. (NYSE: RMD) by 271.3% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional invest
Runnymede Capital Advisors Inc. acquired a new stake in shares of ResMed Inc. (NYSE: RMD) during the undefined quarter, according to the company in its most recent disclosure with the Securities and E
GraniteShares Advisors LLC lessened its position in ResMed Inc. (NYSE: RMD) by 90.6% during the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC)
ResMed Inc. (NYSE: RMD - Get Free Report) Director Peter Farrell sold 2,000 shares of the business's stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average pric
SAN DIEGO, April 01, 2026 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the third quarter of fiscal year 2026 on Thursday,
Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. NVDA, RL, RMD and GE hold promise.
SG Americas Securities LLC decreased its holdings in ResMed Inc. (NYSE: RMD) by 17.9% in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned
ResMed (RMD) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates cou
Danske Bank A S acquired a new stake in shares of ResMed Inc. (NYSE: RMD) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE